Medicines Update

Skin condition warning

The product information for ustekinumab (Stelara) has been updated with a precaution regarding serious skin conditions.

The drug, which is used to treat plaque psoriasis and psoriatic arthritis, has had its PI updated   following a TGA investigation relating to serious skin conditions, namely exfoliative dermatitis (also known as erythroderma) and erythrodermic psoriasis, associated with its use.

To 20 May 2015, the TGA received one report of erythrodermic psoriasis associated with ustekinumab treatment, and no